Lin, Yu
,
Yang, Chao
Chu, Hong
Wu, Jingyi
Lin, Ke
Shi, Ying
Wang, Haibo
Kong, Guilan
Zhang, Luxia
Funding for this research was provided by:
National Natural Science Foundation of China (81771938, 91846101, 81301296)
Grants from Peking University (BMU2018MX020, PKU2017LCX05)
the National Key Technology R&D Program of the Ministry of Science and Technology of the People's Republic of China (2016YFC1305400)
the University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research (BMU20160466)
Article History
Received: 5 May 2019
Accepted: 27 August 2019
First Online: 7 October 2019
Ethics approval and consent to participate
: The Ethics Committee of Peking University First Hospital reviewed and approved the study. Acquisition of informed consent was exempted.
: Not applicable.
: Luxia Zhang received research funding from AstraZeneca. The remaining authors declare that they have no competing interests.